Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Neonicotinoids disrupt aquatic food webs and decrease fishery yields.

Yamamuro M, Komuro T, Kamiya H, Kato T, Hasegawa H, Kameda Y.

Science. 2019 Nov 1;366(6465):620-623. doi: 10.1126/science.aax3442.

PMID:
31672894
2.

Microscopic polyangiitis associated with subarachnoid hemorrhage.

Ihara K, Kimura M, Yamamuro M, Inoshita S.

J Rural Med. 2019 May;14(1):125-131. doi: 10.2185/jrm.2971. Epub 2019 May 30.

3.

Light quality determines primary production in nutrient-poor small lakes.

Tanabe Y, Hori M, Mizuno AN, Osono T, Uchida M, Kudoh S, Yamamuro M.

Sci Rep. 2019 Mar 15;9(1):4639. doi: 10.1038/s41598-019-41003-9.

4.

Prediction of glandularity and breast radiation dose from mammography results in Japanese women.

Yamamuro M, Asai Y, Yamada K, Ozaki Y, Matsumoto M, Murakami T.

Med Biol Eng Comput. 2019 Jan;57(1):289-298. doi: 10.1007/s11517-018-1882-4. Epub 2018 Aug 11.

PMID:
30099671
5.

A case of perinatal hypophosphatasia with a novel mutation in the ALPL gene: clinical course and review of the literature.

Oyachi M, Harada D, Sakamoto N, Ueyama K, Kondo K, Kishimoto K, Izui M, Nagamatsu Y, Kashiwagi H, Yamamuro M, Tamura M, Kikuchi S, Akiyama T, Michigami T, Seino Y, Namba N.

Clin Pediatr Endocrinol. 2018;27(3):179-186. doi: 10.1297/cpe.27.179. Epub 2018 Jul 31.

6.

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction.

Ishii M, Kaikita K, Sato K, Sueta D, Fujisue K, Arima Y, Oimatsu Y, Mitsuse T, Onoue Y, Araki S, Yamamuro M, Nakamura T, Izumiya Y, Yamamoto E, Kojima S, Kim-Mitsuyama S, Ogawa H, Tsujita K.

JACC Basic Transl Sci. 2017 Dec 25;2(6):655-668. doi: 10.1016/j.jacbts.2017.08.001. eCollection 2017 Dec.

7.

Clinical significance of brachial-ankle pulse-wave velocity in patients with heart failure with preserved left ventricular ejection fraction.

Tokitsu T, Yamamoto E, Oike F, Hirata Y, Tsujita K, Yamamuro M, Kaikita K, Hokimoto S.

J Hypertens. 2018 Mar;36(3):560-568. doi: 10.1097/HJH.0000000000001589.

PMID:
29084082
8.

Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.

Nakayama M, Yamamuro M, Takashio S, Uemura T, Nakayama N, Hirakawa K, Oda S, Utsunomiya D, Kaikita K, Hokimoto S, Yamashita Y, Morita Y, Kimura K, Tamura K, Tsujita K.

Heart Vessels. 2018 Apr;33(4):393-402. doi: 10.1007/s00380-017-1069-1. Epub 2017 Oct 19.

PMID:
29051976
9.

Time-resolved Fluorescent Detection for Glucose Using a Complex of Luminescent Layered Titanates and Enzymes.

Sakaguchi Y, Minamikawa T, Yamamuro M, Tsujita T, Ueda T, Kamada K, Soh N.

Anal Sci. 2017;33(9):989-991. doi: 10.2116/analsci.33.989.

10.

Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.

Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Marume K, Yamamoto M, Ueda M, Yamashita T, Ishibashi-Ueda H, Yasuda S, Ogawa H, Ando Y, Anzai T, Tsujita K.

ESC Heart Fail. 2018 Feb;5(1):27-35. doi: 10.1002/ehf2.12203. Epub 2017 Sep 4.

11.

Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System.

Ishii M, Kaikita K, Ito M, Sueta D, Arima Y, Takashio S, Izumiya Y, Yamamoto E, Yamamuro M, Kojima S, Hokimoto S, Yamabe H, Ogawa H, Tsujita K.

Sci Rep. 2017 Aug 7;7(1):7399. doi: 10.1038/s41598-017-07939-6.

12.

Changes in the risk factors for coronary spasm.

Ishii M, Kaikita K, Sato K, Yamanaga K, Miyazaki T, Akasaka T, Tabata N, Arima Y, Sueta D, Sakamoto K, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Soejima H, Hokimoto S, Matsui K, Ogawa H.

Int J Cardiol Heart Vasc. 2016 Aug 5;12:85-87. doi: 10.1016/j.ijcha.2016.07.008. eCollection 2016 Sep. No abstract available.

13.

Final adult height in long-term growth hormone-treated achondroplasia patients.

Harada D, Namba N, Hanioka Y, Ueyama K, Sakamoto N, Nakano Y, Izui M, Nagamatsu Y, Kashiwagi H, Yamamuro M, Ishiura Y, Ogitani A, Seino Y.

Eur J Pediatr. 2017 Jul;176(7):873-879. doi: 10.1007/s00431-017-2923-y. Epub 2017 May 13.

14.

Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy.

Oda S, Utsunomiya D, Morita K, Nakaura T, Yuki H, Kidoh M, Hirata K, Taguchi N, Tsuda N, Shiraishi S, Namimoto T, Hirakawa K, Takashio S, Izumiya Y, Yamamuro M, Hokimoto S, Tsujita K, Ueda M, Yamashita T, Ando Y, Yamashita Y.

Eur Radiol. 2017 Nov;27(11):4631-4638. doi: 10.1007/s00330-017-4845-5. Epub 2017 May 5.

PMID:
28477167
15.

Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging.

Oda S, Utsunomiya D, Nakaura T, Yuki H, Kidoh M, Morita K, Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Ishida T, Tsujita K, Ueda M, Yamashita T, Ando Y, Hata H, Yamashita Y.

Circ J. 2017 Jun 23;81(7):1014-1021. doi: 10.1253/circj.CJ-16-1259. Epub 2017 Mar 31.

16.

Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis.

Hirakawa K, Yamamuro M, Uemura T, Takashio S, Kaikita K, Utsunomiya D, Nakayama M, Yamamoto E, Yamashita Y, Hokimoto S, Tsujita K.

Int J Cardiol. 2017 Feb 1;228:881-885. doi: 10.1016/j.ijcard.2016.11.054. Epub 2016 Nov 8.

PMID:
27889555
17.

Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.

Yamamura S, Izumiya Y, Ishida T, Onoue Y, Kimura Y, Hanatani S, Araki S, Fujisue K, Sueta D, Kanazawa H, Takashio S, Usuku H, Sugamura K, Sakamoto K, Yamamoto E, Yamamuro M, Yasuda H, Kojima S, Kaikita K, Hokimoto S, Ogawa H, Tsujita K.

Heart Vessels. 2017 Jun;32(6):708-713. doi: 10.1007/s00380-016-0925-8. Epub 2016 Nov 23.

PMID:
27882404
18.

A Destabilized Case of Stable Effort Angina Pectoris Induced by Low-dose Adenosine Triphosphate.

Sueta D, Kojima S, Izumiya Y, Yamamuro M, Kaikita K, Hokimoto S, Ogawa H.

Intern Med. 2016;55(22):3291-3294. Epub 2016 Nov 15.

19.

Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction.

Tabata N, Sueta D, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Hokimoto S.

PLoS One. 2016 Nov 10;11(11):e0166240. doi: 10.1371/journal.pone.0166240. eCollection 2016.

20.

Improvement in Microvascular Ischemia After Enzyme Replacement Therapy in Anderson-Fabry Disease - Computed Tomography Myocardial Perfusion Imaging.

Yuki H, Utsunomiya D, Izumiya Y, Oda S, Kidoh M, Takashio S, Yamamuro M, Hokimoto S, Yamashita Y.

Circ J. 2017 Jan 25;81(2):243-244. doi: 10.1253/circj.CJ-16-0873. Epub 2016 Oct 25. No abstract available.

21.

The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction.

Yamamoto E, Hirata Y, Tokitsu T, Kusaka H, Tabata N, Tsujita K, Yamamuro M, Kaikita K, Watanabe H, Hokimoto S, Maruyama T, Ogawa H.

ESC Heart Fail. 2016 Mar;3(1):53-59. Epub 2015 Nov 9.

22.

Colorimetric Determination of Sulfide in Microsamples.

Sugahara S, Suzuki M, Kamiya H, Yamamuro M, Semura H, Senga Y, Egawa M, Seike Y.

Anal Sci. 2016;32(10):1129-1131.

23.

Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina.

Akasaka T, Sueta D, Arima Y, Tabata N, Takashio S, Izumiya Y, Yamamoto E, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogata Y, Matsui K, Hokimoto S.

Am J Physiol Heart Circ Physiol. 2016 Dec 1;311(6):H1409-H1415. doi: 10.1152/ajpheart.00473.2016. Epub 2016 Sep 23.

24.

A rare case of long-term survival with idiopathic dilatation of the pulmonary artery.

Sueta D, Sugamura K, Shimizu H, Shiota T, Yamamuro M, Hirakawa K, Sakamoto K, Tsujita K, Hanatani S, Yamamoto E, Araki S, Kanazawa H, Kojima S, Kaikita K, Hokimoto S, Komohara Y, Ogawa H.

Int J Cardiol. 2016 Nov 15;223:337-339. doi: 10.1016/j.ijcard.2016.08.110. Epub 2016 Aug 13. No abstract available.

PMID:
27543705
25.

Prevalence of coronary macro- and micro-vascular dysfunctions after drug-eluting stent implantation without in-stent restenosis.

Hokimoto S, Tabata N, Yamanaga K, Sueta D, Akasaka T, Tsujita K, Sakamoto K, Yamamoto E, Yamamuro M, Izumiya Y, Kaikita K, Kojima S, Matsui K, Ogawa H.

Int J Cardiol. 2016 Nov 1;222:185-194. doi: 10.1016/j.ijcard.2016.07.221. Epub 2016 Jul 30.

PMID:
27497093
26.

Impact of aspirin on the prognosis in patients with coronary spasm without significant atherosclerotic stenosis.

Ishii M, Kaikita K, Sato K, Yamanaga K, Miyazaki T, Akasaka T, Tabata N, Arima Y, Sueta D, Sakamoto K, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Soejima H, Hokimoto S, Matsui K, Ogawa H.

Int J Cardiol. 2016 Oct 1;220:328-32. doi: 10.1016/j.ijcard.2016.06.157. Epub 2016 Jun 29.

PMID:
27390950
27.

Clinical and morphological presentations of acute coronary syndrome without coronary plaque rupture - An intravascular ultrasound study.

Tsujita K, Yamanaga K, Komura N, Sakamoto K, Miyazaki T, Oimatsu Y, Ishii M, Tabata N, Akasaka T, Sueta D, Yamamoto E, Yamamuro M, Izumiya Y, Kojima S, Nakamura S, Kaikita K, Hokimoto S, Ogawa H.

Int J Cardiol. 2016 Oct 1;220:112-5. doi: 10.1016/j.ijcard.2016.06.191. Epub 2016 Jun 25.

PMID:
27376565
28.

Impaired Peripheral Endothelial Function Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis.

Komura N, Tsujita K, Yamanaga K, Sakamoto K, Kaikita K, Hokimoto S, Iwashita S, Miyazaki T, Akasaka T, Arima Y, Yamamoto E, Izumiya Y, Yamamuro M, Kojima S, Tayama S, Sugiyama S, Matsui K, Nakamura S, Hibi K, Kimura K, Umemura S, Ogawa H.

J Am Heart Assoc. 2016 Jun 17;5(6). pii: e003202. doi: 10.1161/JAHA.116.003202.

29.

Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm.

Ishii M, Kaikita K, Sato K, Yamanaga K, Miyazaki T, Akasaka T, Tabata N, Arima Y, Sueta D, Sakamoto K, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Soejima H, Hokimoto S, Matsui K, Ogawa H.

J Am Heart Assoc. 2016 May 20;5(5). pii: e003426. doi: 10.1161/JAHA.116.003426.

30.

A simple sarcopenia screening test predicts future adverse events in patients with heart failure.

Onoue Y, Izumiya Y, Hanatani S, Tanaka T, Yamamura S, Kimura Y, Araki S, Sakamoto K, Tsujita K, Yamamoto E, Yamamuro M, Kojima S, Kaikita K, Hokimoto S.

Int J Cardiol. 2016 Jul 15;215:301-6. doi: 10.1016/j.ijcard.2016.04.128. Epub 2016 Apr 17.

PMID:
27128551
31.

Distribution of Ankle-Brachial Index among Inpatients with Cardiovascular Disease: Analysis Using the Kumamoto University Hospital Medical Database.

Hokimoto S, Soejima H, Kojima S, Kaikita K, Yamamuro M, Izumiya Y, Tsujita K, Yamamoto E, Tanaka T, Sugamura K, Arima Y, Sakamoto K, Akasaka T, Tabata N, Sueta D, Miyoshi I, Usami M, Ogawa H.

Ann Vasc Dis. 2016;9(1):22-9. doi: 10.3400/avd.oa.15-00089. Epub 2016 Jan 5.

32.

Helicobacter Pylori-seropositivity along with genetic and environmental factors predicts clinical outcome after acute coronary syndrome.

Tabata N, Hokimoto S, Akasaka T, Sueta D, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogawa H.

Int J Cardiol. 2016 Jun 1;212:54-6. doi: 10.1016/j.ijcard.2016.03.034. Epub 2016 Mar 16. No abstract available.

PMID:
27019048
33.

Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder.

Akasaka T, Hokimoto S, Sueta D, Tabata N, Sakamoto K, Yamamoto E, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogata Y, Ogawa H.

Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1494-500. doi: 10.1152/ajpheart.00911.2015. Epub 2016 Mar 18.

34.

Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure.

Uemura T, Yamamuro M, Kaikita K, Takashio S, Utsunomiya D, Hirakawa K, Nakayama M, Sakamoto K, Yamamoto E, Tsujita K, Kojima S, Hokimoto S, Yamashita Y, Ogawa H.

Heart Vessels. 2016 Dec;31(12):1969-1979. Epub 2016 Feb 18.

35.

Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Ito M, Kaikita K, Sueta D, Ishii M, Oimatsu Y, Arima Y, Iwashita S, Takahashi A, Hoshiyama T, Kanazawa H, Sakamoto K, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Hokimoto S, Yamabe H, Ogawa H.

J Am Heart Assoc. 2016 Jan 25;5(1). pii: e002744. doi: 10.1161/JAHA.115.002744.

36.

Determinants of Myocardial Lactate Production During Acetylcholine Provocation Test in Patients With Coronary Spasm.

Kaikita K, Ishii M, Sato K, Nakayama M, Arima Y, Tanaka T, Sugamura K, Sakamoto K, Izumiya Y, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Soejima H, Hokimoto S, Matsui K, Ogawa H.

J Am Heart Assoc. 2015 Dec 11;4(12). pii: e002387. doi: 10.1161/JAHA.115.002387.

37.

Nocturia in Patients With Sleep-Disordered Breathing and Cardiovascular Disease.

Miyazaki T, Kojima S, Yamamuro M, Sakamoto K, Izumiya Y, Tsujita K, Yamamoto E, Tanaka T, Kaikita K, Hokimoto S, Ogawa H.

Circ J. 2015;79(12):2632-40. doi: 10.1253/circj.CJ-15-0654. Epub 2015 Oct 19.

38.

Acetylcholine-Provoked Coronary Spasm at Site of Significant Organic Stenosis Predicts Poor Prognosis in Patients With Coronary Vasospastic Angina.

Ishii M, Kaikita K, Sato K, Tanaka T, Sugamura K, Sakamoto K, Izumiya Y, Yamamoto E, Tsujita K, Yamamuro M, Kojima S, Soejima H, Hokimoto S, Matsui K, Ogawa H.

J Am Coll Cardiol. 2015 Sep 8;66(10):1105-15. doi: 10.1016/j.jacc.2015.06.1324.

39.

A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study.

Ogawa H, Soejima H, Matsui K, Kim-Mitsuyama S, Yasuda O, Node K, Yamamuro M, Yamamoto E, Kataoka K, Jinnouchi H, Sekigami T; ATTEMPT-CVD investigators.

Eur J Prev Cardiol. 2016 Jun;23(9):913-21. doi: 10.1177/2047487315603221. Epub 2015 Aug 31.

PMID:
26324672
40.

Physiological basis of discordance between coronary flow velocity reserve and hyperemic microvascular resistance for evaluating coronary microvascular dysfunction in patients without atherosclerotic obstruction.

Yamanaga K, Tsujita K, Komura N, Kaikita K, Sakamoto K, Miyazaki T, Saito M, Ishii M, Tabata N, Akasaka T, Arima Y, Yamamoto E, Yamamuro M, Izumiya Y, Kojima S, Tayama S, Nakamura S, Hokimoto S, Ogawa H.

Int J Cardiol. 2015 Dec 15;201:535-7. doi: 10.1016/j.ijcard.2015.08.102. Epub 2015 Aug 14. No abstract available.

PMID:
26322602
41.

Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.

Tabata N, Hokimoto S, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Tsujita K, Izumiya Y, Yamamuro M, Kojima S, Kaikita K, Ogawa H.

Heart Vessels. 2016 Jul;31(7):1038-44. doi: 10.1007/s00380-015-0713-x. Epub 2015 Jul 12.

PMID:
26164597
42.

Overview of the 79th Annual Scientific Meeting of the Japanese Circulation Society – Late-Breaking Cardiovascular Medicine From Japan.

Hokimoto S, Yasuda S, Sueta D, Tsujita K, Sakamoto K, Yamamuro M, Izumiya Y, Arima Y, Usuku H, Sumida Y, Kojima S, Kaikita K, Kanazawa H, Yamabe H, Ogawa H.

Circ J. 2015;79(8):1675-9. doi: 10.1253/circj.CJ-15-0675. Epub 2015 Jul 3.

43.

Significance of low plasma levels of brain-derived neurotrophic factor in patients with heart failure.

Takashio S, Sugiyama S, Yamamuro M, Takahama H, Hayashi T, Sugano Y, Izumiya Y, Hokimoto S, Minamino N, Yasuda S, Anzai T, Ogawa H.

Am J Cardiol. 2015 Jul 15;116(2):243-9. doi: 10.1016/j.amjcard.2015.04.018. Epub 2015 Apr 18.

PMID:
25983281
44.

The pivotal role of eNOS uncoupling in vascular endothelial dysfunction in patients with heart failure with preserved ejection fraction.

Yamamoto E, Hirata Y, Tokitsu T, Kusaka H, Sakamoto K, Yamamuro M, Kaikita K, Watanabe H, Hokimoto S, Sugiyama S, Maruyama T, Ogawa H.

Int J Cardiol. 2015;190:335-7. doi: 10.1016/j.ijcard.2015.04.162. Epub 2015 Apr 21. No abstract available.

PMID:
25935623
45.

Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation.

Tabata N, Hokimoto S, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Tsujita K, Izumiya Y, Yamamuro M, Kojima S, Kaikita K, Kumagae N, Morita K, Oniki K, Nakagawa K, Matsui K, Ogawa H.

J Cardiol. 2016 Jan;67(1):104-9. doi: 10.1016/j.jjcc.2015.03.010. Epub 2015 Apr 4.

46.

Impact of left ventricular hypertrophy on impaired coronary microvascular dysfunction.

Tsujita K, Yamanaga K, Komura N, Sakamoto K, Miyazaki T, Ishii M, Tabata N, Akasaka T, Sueta D, Arima Y, Kojima S, Yamamoto E, Yamamuro M, Tanaka T, Izumiya Y, Tayama S, Nakamura S, Kaikita K, Hokimoto S, Ogawa H.

Int J Cardiol. 2015;187:411-3. doi: 10.1016/j.ijcard.2015.03.367. Epub 2015 Mar 26. No abstract available.

PMID:
25841137
47.

Intraprocedural thrombotic event during coronary intervention depends on CYP2C19 genotype and is a predictor of future clinical event.

Marume K, Hokimoto S, Tabata N, Akasaka T, Tsujita K, Sakamoto K, Yamamoto E, Yamamuro M, Kaikita K, Oniki K, Nakagawa K, Ogawa H.

Int J Cardiol. 2015;187:231-3. doi: 10.1016/j.ijcard.2015.03.345. Epub 2015 Mar 24. No abstract available.

PMID:
25838219
48.

Evaluation of appropriateness of second-generation 320-row computed tomography for coronary artery disease.

Utsunomiya D, Oda S, Yuki H, Yamamuro M, Tsujita K, Funama Y, Yoshida M, Kidoh M, Ogawa H, Yamashita Y.

Springerplus. 2015 Mar 5;4:109. doi: 10.1186/s40064-015-0866-1. eCollection 2015.

49.

Fragmented QRS complex is a diagnostic tool in patients with left ventricular diastolic dysfunction.

Onoue Y, Izumiya Y, Hanatani S, Kimura Y, Araki S, Sakamoto K, Yamamoto E, Tsujita K, Tanaka T, Yamamuro M, Kojima S, Kaikita K, Hokimoto S, Ogawa H.

Heart Vessels. 2016 Apr;31(4):563-7. doi: 10.1007/s00380-015-0651-7. Epub 2015 Feb 25.

PMID:
25712607
50.

ST-segment elevation myocardial infarction in a patient with anomalous origin of left circumflex coronary artery.

Yamamoto M, Tsujita K, Yamanaga K, Komura N, Sakamoto K, Kojima S, Yamamoto E, Tanaka T, Yamamuro M, Izumiya Y, Nakamura S, Kaikita K, Hokimoto S, Ogawa H.

J Cardiol Cases. 2015 Feb 13;11(4):120-123. doi: 10.1016/j.jccase.2015.01.002. eCollection 2015 Apr.

Supplemental Content

Loading ...
Support Center